131 related articles for article (PubMed ID: 36799501)
1. Changes in Stage at Presentation among Lung and Breast Cancer Patients During the COVID-19 Pandemic.
Mallouh M; Linshaw D; Barton B; De La Cruz G; Dinh K; LaFemina J; Vijayaraghavan G; Larkin A; Whalen G
J Am Coll Surg; 2023 Jun; 236(6):1164-1170. PubMed ID: 36799501
[TBL] [Abstract][Full Text] [Related]
2. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
[TBL] [Abstract][Full Text] [Related]
4. The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center.
Lou J; Kooragayala K; Williams JP; Sandilos G; Butchy MV; Yoon-Flannery K; Kwiatt M; Hong YK; Shersher DD; Burg JM
Am J Clin Oncol; 2022 Sep; 45(9):381-390. PubMed ID: 35983965
[TBL] [Abstract][Full Text] [Related]
5. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system.
Greene G; Griffiths R; Han J; Akbari A; Jones M; Lyons J; Lyons RA; Rolles M; Torabi F; Warlow J; Morris ERA; Lawler M; Huws DW
Br J Cancer; 2022 Aug; 127(3):558-568. PubMed ID: 35501391
[TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19-related health care disruptions on pathologic cancer staging during the first pandemic year: a retrospective cohort study from March 2018 to March 2021.
Tran C; Cipriano LE; Driman DK
CMAJ Open; 2023; 11(3):E475-E484. PubMed ID: 37279981
[TBL] [Abstract][Full Text] [Related]
7. Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic.
Doan C; Li S; Goodwin JS
JAMA Netw Open; 2023 Feb; 6(2):e2255589. PubMed ID: 36735262
[TBL] [Abstract][Full Text] [Related]
8. Pattern of breast cancer presentation during the COVID-19 pandemic: results from a cohort study in the UK.
Borsky K; Shah K; Cunnick G; Tsang-Wright F
Future Oncol; 2022 Feb; 18(4):437-443. PubMed ID: 35018787
[TBL] [Abstract][Full Text] [Related]
9. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
10. Bend but don't break: Experience of a diverse New York City lung cancer screening program during the first year of the COVID-19 pandemic.
Stahl MC; Shamah S; Wattamwar K; Furlani AC; Serrano M; Haramati LB
Clin Imaging; 2023 Aug; 100():1-6. PubMed ID: 37120922
[TBL] [Abstract][Full Text] [Related]
11. Are Breast Cancer Patients Presenting With Higher Stage Since the COVID-19 Pandemic?
Cairns A; Inman I; Perko A; Martin T; Chiba A; Howard-McNatt M
Am Surg; 2023 Sep; 89(9):3784-3787. PubMed ID: 37260157
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021.
Malmgren JA; Guo B; Atwood MK; Hallam P; Roberts LA; Kaplan HG
Breast Cancer Res Treat; 2023 Nov; 202(1):105-115. PubMed ID: 37584882
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the impact of COVID-19 on cancer declarations in Quebec, Canada.
Ramanakumar AV; Annie B; Frederic L; Christine B; Cathy R; Jean L
Cancer Med; 2023 Mar; 12(5):6260-6269. PubMed ID: 36385491
[TBL] [Abstract][Full Text] [Related]
14. Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany.
Kaltofen T; Hagemann F; Harbeck N; Wuerstlein R; Kost BP; Burges A; Mahner S; Trillsch F
Arch Gynecol Obstet; 2022 Mar; 305(3):713-718. PubMed ID: 34491417
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models.
Elek P; Csanádi M; Fadgyas-Freyler P; Gervai N; Oross-Bécsi R; Szécsényi-Nagy B; Tatár M; Váradi B; Zemplényi A
BMJ Open; 2022 Aug; 12(8):e061941. PubMed ID: 35981776
[TBL] [Abstract][Full Text] [Related]
16. Impact of the COVID-19 Pandemic on Cancer Staging: An Analysis of Patients With Breast Cancer From a Community Practice in Brazil.
Resende CAA; Fernandes Cruz HM; Costa E Silva M; Paes RD; Dienstmann R; Barrios CHE; Goncalves AC; Cascelli FGA; Souto AKBA; Oliveira LC; Reinert T; Andrade DAP; Passos MP; Millen EC; Zerwes F; Moraes PL; Ferrari BL; Mano MS
JCO Glob Oncol; 2022 Nov; 8():e2200289. PubMed ID: 36351212
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and meta-analysis of surgery delays and survival in breast, lung and colon cancers: Implication for surgical triage during the COVID-19 pandemic.
Johnson BA; Waddimba AC; Ogola GO; Fleshman JW; Preskitt JT
Am J Surg; 2021 Aug; 222(2):311-318. PubMed ID: 33317814
[TBL] [Abstract][Full Text] [Related]
18. Impact of the COVID-19 Pandemic on Histopathological Diagnosis of Breast Tumours in Calabar, Nigeria.
Udonkang M; Umoh N; Ogba O; Bebia G; Onwineng D; Anku B; Ernest N
Niger J Physiol Sci; 2023 Jun; 38(1):23-28. PubMed ID: 38243356
[TBL] [Abstract][Full Text] [Related]
19. Changes in breast cancer staging trends among Egyptian women after COVID-19: A retrospective single-center study.
Abd El Wahab MH; Ibrahim AH; Gado O; Bahbah AM; Fadlalla W; Fakhry S; Mamdouh MM; Kamel MM; Moaz I; Rabea A; Helal AM
Int J Immunopathol Pharmacol; 2023; 37():3946320231152835. PubMed ID: 36649477
[TBL] [Abstract][Full Text] [Related]
20. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
